SBIR/STTR Research Award

Development of a Point of Care Diagnostic Screening test for Kawasaki disease

Award identifier 564a4916468a101f1c3a4482130389aac2ee2535a2a144b84f692f2ec87f8269Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,963

Program and phase

STTR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
L2 DIAGNOSTICS LLC
Proposal award date
2018-08-11
Contract end date
2019-07-31
UEI
GKA7VH5LFR25
Solicitation number
PA17-303
Topic code
NICHD

Research abstract

ABSTRACT Kawasaki DiseaseKDis a febrile childhood vasculitis with potentially catastrophic clinical outcomesUntreatedone in five children develop coronary artery aneurysms causing significant morbidity and mortalityTypical KD presents as a febrile illness andgtdays in children andltyears oldThere are no diagnostic tests for KDit is diagnosed clinically based on a fever andgtdays with at leastofphysical findingsPediatricians who have not seen and treated KD tend to be insecure about making a KD diagnosisHoweversending home a child with KD can be disastrousHelping pediatricians make a diagnosis of KD is therefore a vital unmet medical needWe recently published a study of KD subjects and showed thatunlike other febrile conditionsKD is characterized by an elevated serum level of sTNFRIIapproximatelyfold higher than normalReference laboratory tests for sTNFRII are no longer available and had long turnaround times when they wereWe propose to develop a point of care test based on sTNFRII that can be used in pediatriciansoffices and emergency departments to rapidly and reliably exclude the diagnosis of KD in febrile childrenWe will develop lateral flow chromatography devices capable of detecting sTNFRII in human serum samples in a semiquantitative mannerThese devices will be based on existing polyclonal and monoclonal antibodies against sTNFRIIWe will also derive new rat monoclonal antibodies to increase the number of reagents at our disposal and to ensure optimal sensitivity and specificityThe performance of the lateral flow assay devices will be measured on human serum spiked with known concentrations of recombinant sTNFRIIIf the devices allow the user to distinguish a normal from an elevated concentration of sTNFRIIwe will analyze serum samples from our published study to confirm that the point of care test gives results identical to reference laboratory testsIf Phase I is successfulthe lateral flow devices will be used in Phase II experiments organized around a multicenter clinical trial NARRATIVE Kawasaki disease is a disease of children that can have devastating consequences and even be fatal within days if not correctly diagnosedWe have recently shown that patients with Kawasaki disease have an elevated serum level of sTNFRIIWe propose to develop a rapid test measuring sTNFRII that could be run by emergency departments and pediatricians in their officeThis would help in the rapid and cost effective diagnosis of Kawasaki disease

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

84 SBIR/STTR records share this UEI (1999–2025). Reported award amounts total $45,551,124. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.